Avalyn Pharma Inc. (AVLN)
Nasdaq: AVLN · Pharmaceutical Preparations · filing with the SEC since 2012
Who runs Avalyn Pharma Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Baranowski Lyn
Chief Executive Officer. First filing Apr 2026, latest May 1, 2026, 0 filings in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
12 people on the record since 2026
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Golden Adam H. | General Counsel | Apr 2026 | May 4, 2026 | none |
| Baranowski Lyn | Chief Executive Officer | Apr 2026 | May 1, 2026 | none |
| Carlson Douglas R | Chief Financial Officer | Apr 2026 | May 1, 2026 | none |
| Rhodes Melissa | Chief Operating Officer | Apr 2026 | May 1, 2026 | none |
| Lazarus Howard | Chief Medical Officer | Apr 2026 | May 1, 2026 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Meyer Robert J. | director | Sep 2026 | Sep 17, 2026 | none |
| Carroll Jill | director | Apr 2026 | May 1, 2026 | none |
| Congleton Jon | director | Apr 2026 | May 1, 2026 | none |
| Haviland Kate | director | Apr 2026 | May 1, 2026 | none |
| Lavelle Erin | director | Apr 2026 | May 1, 2026 | none |
| Turner Heather D | director | Apr 2026 | May 1, 2026 | none |
| Friedman David Matthew | director | Apr 2026 | Apr 29, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Fmr LLC | 10% owner | Apr 2026 | Nov 12, 2026 | 4 · $6.7M |
| Novo Holdings A/s | 10% owner | Apr 2026 | May 5, 2026 | none |
| George Simeon | 10% owner | Apr 2026 | May 1, 2026 | none |
| Sr One Capital Management, LLC | 10% owner | Apr 2026 | May 1, 2026 | none |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% owner | Apr 2026 | May 1, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.